Articles from China Medical System Holdings Limited

CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China

By China Medical System Holdings Limited · Via ACN Newswire · April 23, 2026

CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets

By China Medical System Holdings Limited · Via ACN Newswire · July 21, 2025